CARLY SWINT: Open Payments
NPI 1407374408 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 61 payments from 14 companies in 2025. Trend: 2023 $854 · 2024 $2,327 · 2025 $1,370
Food & beverage: $1,320Education: $50
| Company | Payments | Amount |
|---|---|---|
| Cycle Pharmaceuticals Inc | 9 | $214 |
| Ionis Pharmaceuticals, Inc. | 9 | $207 |
| CSL Behring | 8 | $205 |
| GENZYME CORPORATION | 7 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $117 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| Pharming Healthcare, Inc. | 3 | $68 |
| Grifols USA, LLC | 2 | $40 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
Products named: Sajazir, TEZSPIRE, DAWNZERA, Andembry, DUPIXENT, AYVAKIT, RUCONEST, TAKHZYRO.
Industry payments across CO — which companies pay providers there.
